Deep brain stimulation of the subthalamic nucleus in obsessive-compulsives disorders: long-term follow-up of an open, prospective, observational cohort.
Journal
Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
05
04
2020
revised:
01
07
2020
accepted:
31
08
2020
pubmed:
10
10
2020
medline:
23
3
2021
entrez:
9
10
2020
Statut:
ppublish
Résumé
Obsessive-compulsive disorder (OCD) is a major cause of disability in western country and responsible for severe impairment of quality of life. About 10% of patients present with severe OCD symptoms and require innovative treatment such as deep brain stimulation (DBS). Among possible targets, the non-motor subthalamic nucleus (STN) is a key node of the basal ganglia circuitry, strongly connected to limbic cortical areas known to be involved in OCD. We analysed, in a prospective, observational, monocentric, open label cohort, the effect of chronic non-motor STN-DBS in 19 patients with treatment-resistant OCD consecutively operated in a single centre. Severity of OCD was evaluated using the Yale and Brown Obsessive-Compulsive Scale (YBOCS). YBOCS scores at 6, 12 and 24 months postoperatively were compared with baseline. Responders were defined by >35% improvement of YBOCS scores. Global Assessment Functioning (GAF) scale was used to evaluate the impact of improvement. At a 24-month follow-up, the mean YBOCS score improved by 53.4% from 33.3±3.5 to 15.8±9.1 (95% CI 11.2-20.4; p<0.0001). Fourteen out of 19 patients were considered as responders, 5 out of 19 being improved over 75% and 10 out of 19 over 50%. GAF scale improved by 92% from 34.1±3.9 to 66.4±18.8 (95% CI 56.7-76.1; p=0.0003). The most frequent adverse events consisted of transient DBS-induced hypomania and anxiety. Chronic DBS of the non-motor STN is an effective and relatively safe procedure to treat severe OCD resistant to conventional management.
Sections du résumé
BACKGROUND
Obsessive-compulsive disorder (OCD) is a major cause of disability in western country and responsible for severe impairment of quality of life. About 10% of patients present with severe OCD symptoms and require innovative treatment such as deep brain stimulation (DBS). Among possible targets, the non-motor subthalamic nucleus (STN) is a key node of the basal ganglia circuitry, strongly connected to limbic cortical areas known to be involved in OCD.
METHOD
We analysed, in a prospective, observational, monocentric, open label cohort, the effect of chronic non-motor STN-DBS in 19 patients with treatment-resistant OCD consecutively operated in a single centre. Severity of OCD was evaluated using the Yale and Brown Obsessive-Compulsive Scale (YBOCS). YBOCS scores at 6, 12 and 24 months postoperatively were compared with baseline. Responders were defined by >35% improvement of YBOCS scores. Global Assessment Functioning (GAF) scale was used to evaluate the impact of improvement.
RESULTS
At a 24-month follow-up, the mean YBOCS score improved by 53.4% from 33.3±3.5 to 15.8±9.1 (95% CI 11.2-20.4; p<0.0001). Fourteen out of 19 patients were considered as responders, 5 out of 19 being improved over 75% and 10 out of 19 over 50%. GAF scale improved by 92% from 34.1±3.9 to 66.4±18.8 (95% CI 56.7-76.1; p=0.0003). The most frequent adverse events consisted of transient DBS-induced hypomania and anxiety.
CONCLUSION
Chronic DBS of the non-motor STN is an effective and relatively safe procedure to treat severe OCD resistant to conventional management.
Identifiants
pubmed: 33033168
pii: jnnp-2020-323421
doi: 10.1136/jnnp-2020-323421
pmc: PMC7677463
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1349-1356Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Trends Neurosci. 1989 Oct;12(10):366-75
pubmed: 2479133
Mov Disord. 2015 Feb;30(2):128-40
pubmed: 25297382
Brain Stimul. 2019 Jul - Aug;12(4):1080-1082
pubmed: 30992192
Neurology. 2006 Jan 10;66(1):142-3
pubmed: 16401868
Compr Psychiatry. 2008 Jan-Feb;49(1):43-50
pubmed: 18063040
Psychiatr Clin North Am. 1992 Dec;15(4):743-58
pubmed: 1461792
Biol Psychiatry. 2014 Apr 15;75(8):595-605
pubmed: 24314349
Transl Psychiatry. 2019 Feb 4;9(1):73
pubmed: 30718450
Mol Psychiatry. 2017 Nov;22(11):1626-1632
pubmed: 27431293
Brain. 2017 Feb;140(2):442-456
pubmed: 28040671
Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10661-6
pubmed: 17556546
Mol Psychiatry. 2016 Sep;21(9):1272-80
pubmed: 26303665
Neuroimage. 2007 Jan 15;34(2):618-38
pubmed: 17110133
Lancet. 1999 Oct 30;354(9189):1526
pubmed: 10551504
J Neurosurg. 2004 Jun;100(6):1084-6
pubmed: 15200126
Mol Psychiatry. 2017 Jun;22(6):931-934
pubmed: 27480493
Epileptic Disord. 2002 Dec;4 Suppl 3:S83-93
pubmed: 12495878
Lancet Neurol. 2014 Mar;13(3):287-305
pubmed: 24556007
Neuropsychopharmacology. 2010 Jan;35(1):317-36
pubmed: 19759530
Neurology. 2019 Jul 2;93(1):e97-e105
pubmed: 31101738
Prog Neurobiol. 2004 Feb;72(3):195-221
pubmed: 15130710
Lancet Neurol. 2009 Jan;8(1):67-81
pubmed: 19081516
Biol Psychiatry. 2019 May 1;85(9):726-734
pubmed: 30853111
Psychiatr Clin North Am. 2006 Jun;29(2):553-84, xi
pubmed: 16650723
Arch Gen Psychiatry. 2010 Oct;67(10):1061-8
pubmed: 20921122
Am J Psychiatry. 1986 Mar;143(3):317-22
pubmed: 3953865
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jun;3(6):563-571
pubmed: 29550459
Neurology. 2016 Oct 25;87(17):1843-1844
pubmed: 27655738
Lancet. 2002 Oct 26;360(9342):1302-4
pubmed: 12414208
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1113-8
pubmed: 23667214
Mov Disord. 2014 Mar;29(3):305
pubmed: 24375493
JAMA Psychiatry. 2013 Jun;70(6):619-29
pubmed: 23740050
J Neurosci. 2013 Mar 13;33(11):4804-14
pubmed: 23486951
N Engl J Med. 2008 Nov 13;359(20):2121-34
pubmed: 19005196
PLoS One. 2015 Aug 27;10(8):e0135524
pubmed: 26312488
Brain Stimul. 2015 Mar-Apr;8(2):177-84
pubmed: 25511796
Arch Gen Psychiatry. 2004 Jun;61(6):564-76
pubmed: 15184236
PLoS One. 2015 Jul 24;10(7):e0133591
pubmed: 26208305
Ann Neurol. 2011 May;69(5):793-802
pubmed: 21520240
World Neurosurg. 2013 Sep-Oct;80(3-4):S31.e1-8
pubmed: 22469523